Ms Loretta Little

KANDO id: 19909

Bio

Ms. Little is a managing director and business development manager at WRF Capital. She concentrates primarily in the areas of healthcare and biotechnology and is responsible for identifying and developing startup opportunities and investment decisions in new companies. Ms. Little is WRF Capital's investment manager for GlobeImmune, Targeted Growth, Pacific Bioscience Laboratories/Clarisonic, Corus Pharma (acquired by Gilead Sciences), Accium Bioscience, Amnis, EKOS, and Trace Detect. Additionally, Ms. Little is the investment manager and board observer at Modumetal, Mirador Biomedical and Mobisante. Ms. Little serves on the boards of the Center for Innovation and Entrepreneurship (CIE) at the University of Washington’s Foster School of Business, WINGS – The Washington Medical Technology Angel Network and the Global Social Entrepreneurship Competition. She also does committee work for the Alliance of Angels, the Washington Biotechnology and Biomedical Association, and the Washington Global Health Nexus Working Group. Previously, Ms. Little was manager of technology licensing and acquisitions and senior technology licensing manager. Before joining WRF, she worked as a marketing manager and market consultant. Ms. Little has a bachelor of arts in zoology from Pomona College and a master's in business administration from the University of Arizona.

Education